Gambling with Gastroesophageal Reflux Disease: Should We Worry about the QALY?

Moayyedi, Paul; Talley, Nicholas J.
March 2005
American Journal of Gastroenterology;Mar2005, Vol. 100 Issue 3, p534
Academic Journal
Gastroenterologists mainly deal with chronic organic and functional illnesses that are not life threatening but can be expensive to treat. How this compares with the management of other diseases that cause significant mortality is an important question to answer if health-care resources are to be allocated appropriately. Comparing health care in terms of cost per quality adjusted life year (QALY) gained is one approach to this problem although there are concerns about whose values should be elicited and how QALYs are measured.(Am J Gastroenterol 2005;100:534–536)


Related Articles

  • Medical costs associated with alternative therapies for the treatment of gastroesophageal reflux disease. Sullivan, Erin M; Halpern, Michael T; Lacey, Michael J; Schmier, Jordana; Johnson, David A // American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS236 

    An abstract of the article concerning medical costs linked with alternative therapies for gastroesophageal reflux disease is presented.

  • PPIs VS H2RAs FOR EROSIVE REFLUX ESOPHAGITIS. King, Valerie J. // Journal of Family Practice;Mar1998, Vol. 46 Issue 3, p199 

    This article focuses on a study related to the cost-effectiveness of proton pump inhibitors (PPI) and histamine-2 receptor antagonists in the prevention of erosive reflux esophagitis recurrences. Erosive reflux esophagitis is a moderately common and often recurrent condition. Randomized trials...

  • ATL>The adoption of ablation therapy for Barrett’s esophagus: a cohort study of gastroenterologists. Gross, Cary P.; Cruz-Correa, Marcia; Canto, Marcia Irene; McNeil-Solis, Corlina; Valente, Thomas W.; Powe, Neil R. // American Journal of Gastroenterology;Feb2002, Vol. 97 Issue 2, p279 

    OBJECTIVES:Although ablation therapy may be useful in the treatment of Barrett’s esophagus, evidence of effectiveness is scarce, and little is known about current utilization of ablation. We aimed to determine whether the use of ablation was increasing in a cohort of gastroenterologists,...

  • Is Reflux Cough Due to Gastroesophageal Reflux Disease or Laryngopharyngeal Reflux? Morice, Alyn H. // Lung;Jan/Feb2008 Supplement 1, Vol. 186, p103 

    Reflux is a common cause of chronic cough. Surveys of patients with chronic cough point to a high association with gastroesophageal disease. Because of our bipedalism and speech, humans are prone to both reflux and aspiration. Whether the reflux of stomach contents into the esophagus alone is...

  • PRESSURES OR VOLUMES IN GASTROESOPHAGEAL REFLUX DISEASE: WHICH IS MOST IMPORTANT? Katz, Philip; Johnson, David A.; Cattau, Edward // American Journal of Gastroenterology;May1990, Vol. 85 Issue 5, p616 

    Comments on a study about the therapeutic significance of the gastric secretory state in gastroesophageal reflux disease. Prevalence of hypersecretion among the patients in the study; Major factor in the development of severe reflux complications; Implications of gastric analysis for...

  • Oesophagogastric Disconnection: Who, How and When? A Review Article. Verey, Frances; Cusick, Eleri // Current Pediatric Reviews;2008, Vol. 4 Issue 2, p103 

    Severe Gastro-oesophageal reflux disease (GORD) is a disabling condition, causing significant morbidity and mortality. Fundoplication has long been seen as the gold standard operative solution, but in 5-43% of patients it will fail. Oesophagogastric disconnection or dissociation (OGD) is a...

  • Ranitidine use is associated with increased morbidity and mortality in very low birthweight infants. Cotten, C. Michael; Malcolm, William F. // Evidence Based Medicine;Feb2013, Vol. 18 Issue 1, p36 

    The article focuses on the issue of use of ranitidine which is associated with increased morbidity and mortality in infants with low birth weight. The cohort study found that demographics and illness severity scores were not different between ranitidine recipients and non-recipients groups. Use...

  • Laryngopharyngeal reflux: Concepts and controversies. Sataloff, Robert T. // ENT: Ear, Nose & Throat Journal;Oct2008, Vol. 87 Issue 10, p549 

    The author reflects on the clinical management of laryngopharyngeal reflux (LPR). He urges otolaryngologists and gastroenterologists to expand their knowledge about the latest concepts in basic science and clinical care of patients with LPR to improve its reporting and diagnosis. He calls for...

  • Prospective Acid Reflux Study of Iran (PARSI): Methodology and study design. Nasseri-Moghaddam, Siavosh; Razjouyan, Hadi; Alimohamadi, Seyed Maysam; Mamarabadi, Mansoureh; Ghotbi, Mohamad-Hamed; Mostajabi, Pardis; Sohrabpour, Amir-Ali; Sotoudeh, Masoud; Abedi, Behnoush; Mofid, Azadeh; Nouraie, Mehdi; Tofangchiha, Shahnaz; Malekzadeh, Reza // BMC Gastroenterology;2007, Vol. 7, p42 

    Background: Gastroesophageal reflux disease is a common and chronic disorder but long term, prospective studies of the fate of patients seeking medical advice are scarce. This is especially prominent when looking at non-erosive reflux disease (NERD) patients. Methods: We designed a prospective...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics